New synthetic inhibitors of fatty acid synthase with anticancer activity
…, M Artola, B Benhamú, S Ortega-Gutiérrez…
Index: Turrado, Carlos; Puig, Teresa; Garcia-Carceles, Javier; Artola, Marta; Benhamu, Bellinda; Ortega-Gutierrez, Silvia; Relat, Joana; Oliveras, Gloria; Blancafort, Adriana; Haro, Diego; Marrero, Pedro F.; Colomer, Ramon; Lopez-Rodriguez, Maria L. Journal of Medicinal Chemistry, 2012 , vol. 55, # 11 p. 5013 - 5023
Full Text: HTML
Citation Number: 31
Abstract
Fatty acid synthase (FASN) is a lipogenic enzyme that is highly expressed in different human cancers. Here we report the development of a new series of polyphenolic compounds 5–30 that have been evaluated for their cytotoxic capacity in SK-Br3 cells, a human breast cancer cell line with high FASN expression. The compounds with an IC50< 50 μM have been tested for their ability to inhibit FASN activity. Among them, derivative 30 blocks the 90% of FASN ...
Related Articles:
[Ren, Yulin; Himmeldirk, Klaus; Chen, Xiaozhuo Journal of Medicinal Chemistry, 2006 , vol. 49, # 9 p. 2829 - 2837]
[Nakazono, Manabu; Ma, Li; Zaitsu, Kiyoshi Tetrahedron Letters, 2002 , vol. 43, # 45 p. 8185 - 8189]